UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000046619
Receipt number R000045060
Scientific Title All-Patient General Drug Use Surveillance of Rozlytrek Capsule -ROS1 fusion gene-positive unresectable advanced or recurrent non-small cell lung cancer-
Date of disclosure of the study information 2022/01/13
Last modified on 2024/07/17 13:54:58

No. Disposal Last modified on Item of update
1 Insert 2022/01/13 07:50:07
2 Update 2022/08/01 10:41:48 Recruitment status
Date of IRB
3 Update 2022/12/28 06:49:35 Email
4 Update 2023/05/30 17:09:02 Email
5 Update 2024/07/17 13:53:52 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
6 Update 2024/07/17 13:54:58 Recruitment status